The influenza A market is expected to surge in the coming years as the emerging therapies which are under development will provide efficient therapeutic approaches with novel mechanisms of action
Increase in usage of mammalian cells for the bioproduction of viral vaccines is likely to drive market growth during the forecast periodRise in demand for reagents and consumables is propelling
The dynamics of the osteoarthritis market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, incremental healthcare spending across the world
Ruling bars ANDA filer Alvogen from entering market until 2032 patent expirySTOUGHTON, Mass., Dec. 22, 2022 Collegium Pharmaceutical, Inc. , a leading, diversified specialty pharmaceutical. | December 22, 2022